Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  biotech  company  june prnewswire  june  new york  new  prnewswire  san francisco  san  therapeutics  york june  york 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Wed, 28 Jun 2017 06:45:03 EDT

Last Build Date: Wed, 28 Jun 2017 06:25:00 EDT

 



Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma

Wed, 28 Jun 2017 06:25:00 EDT

NEW YORK, June 28, 2017 /PRNewswire/ -- If you want a Stock Review on APRI, DRRX, SCMP or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com shifts focus on four Drug Manufacturers stocks, namely:...



Vivace Therapeutics Comes out of Stealth with $40 Million to Turn Novel Biology into First-in-Class Cancer Therapeutics

Wed, 28 Jun 2017 06:15:00 EDT

(image) SAN MATEO, Calif., June 28, 2017 /PRNewswire/ -- Vivace Therapeutics, an oncology-focused portfolio-based drug discovery and development company is coming out of stealth with $40 million raised in Series A and B financings. The company brings together leading scientists, investors and...



Media Files:
http://www.vivacetherapeutics.com




Technical Snapshots for These Biotech Stocks -- Merrimack Pharma, MannKind, GlycoMimetics, and Radius Health

Wed, 28 Jun 2017 06:15:00 EDT

NEW YORK, June 28, 2017 /PRNewswire/ -- If you want a Stock Review on MACK, MNKD, GLYC or RDUS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The Biotech industry includes companies that are engaged in the research and...



Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine

Wed, 28 Jun 2017 03:00:00 EDT

LONDON and NEW YORK, June 28, 2017 /PRNewswire/ -- New programme focused on key GPCR target implicated in aggressive brain cancer Heptares Therapeutics ("Heptares"), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers Index: 4565), announces the launch of a new...



SINOVAC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sinovac Biotech Ltd.

Tue, 27 Jun 2017 17:03:00 EDT

(image) NEW ORLEANS, June 27, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Sinovac Biotech Ltd ("Sinovac" or the "Company") (NASDAQ: SVA) to Sinovac (Cayman)...



Media Files:
https://mma.prnewswire.com/media/399590/KSF_Logo.jpg




Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28

Tue, 27 Jun 2017 16:15:00 EDT

(image) TEL AVIV, Israel, June 27, 2017 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix"), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that the Company will ring The Nasdaq Stock Market Opening...



Media Files:
http://mma.prnewswire.com/media/507393/Therapix_Biosciences_Logo.jpg




Mirati Therapeutics Announces Appointment Of Neil Reisman To The Board Of Directors

Tue, 27 Jun 2017 16:05:00 EDT

(image) SAN DIEGO, June 27, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, today announced the appointment of Neil Reisman to the Company's Board of Directors, effective immediately. Mr. Reisman is a lawyer and...



Media Files:
https://mma.prnewswire.com/media/341355/Mirati_Therapeutics_Inc___Logo.jpg




Reuters Features Medical Marijuana, Inc.'s Major Investment Company AXIM Biotech In Article Citing Company's Development Of Marijuana-Based Painkiller To Combat Opioid Crisis

Tue, 27 Jun 2017 15:13:00 EDT

(image) NEW YORK, June 27, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM), a world leader in cannabinoid...



Media Files:
http://www.medicalmarijuanainc.com




Great Place to Work® and FORTUNE name Roche Diagnostics one of the Best Workplaces for Millennials

Tue, 27 Jun 2017 13:33:00 EDT

(image) INDIANAPOLIS, June 27, 2017 /PRNewswire/ -- Roche Diagnostics was named as #67 on the list of the country's Best Workplaces for Millennials, announced by research and consulting firm Great Place to Work and FORTUNE. The ranking considered 398,000 surveys that assessed organizations'...



Media Files:
https://mma.prnewswire.com/media/528433/Roche_Millennials.jpg




New Jersey Health Foundation Supports Rutgers TechAdvance Fund With $500,000 Commitment; Encourages Others to Follow Lead

Tue, 27 Jun 2017 13:25:00 EDT

(image) NEW BRUNSWICK, N.J., June 27, 2017 /PRNewswire-USNewswire/ -- New Jersey Health Foundation (NJHF) made its first $100,000 contribution on a $500,000 pledge over five years to support the new Rutgers University TechAdvance Fund, a program intended to advance Rutgers technologies headed...



Media Files:
http://www.njhealthfoundation.org




3D Cell Culture Market Key Manufacturers Corning, 3D Biotek and Lonza Group Says A New Research at ReportsnReports

Tue, 27 Jun 2017 12:00:00 EDT

PUNE, India, June 27, 2017 /PRNewswire/ -- 3D Cell Culture Industry 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market....



New Employers Listed For 8th Annual Life Science Hiring Event

Tue, 27 Jun 2017 10:17:00 EDT

(image) ROOSEVELT, N.J., June 27, 2017 /PRNewswire/ -- HireLifeScience.com, the premier career networking website for the Life Science industries, will host its 8th annual career fair at The NJ Convention and Exposition Center at Raritan Center in Edison, NJ on September 26, 2017.  Novo Nordisk is...



Media Files:
http://www.HireLifeScience.com




CCRM to Open State-of-the-Art Fertility Clinic in San Francisco Bay Area

Tue, 27 Jun 2017 10:00:00 EDT

(image) SAN FRANCISCO, June 27, 2017 /PRNewswire/ -- Committed to expanding access to the highest quality of fertility care available, the CCRM Network is opening a new location in the San Francisco Bay Area on June 28. CCRM San Francisco is co-founded by board certified reproductive...



Media Files:
https://mma.prnewswire.com/media/514985/CCRM__Logo.jpg




Dr. Joan Fallon, CEO of Curemark, Named EY Entrepreneur Of The Year® 2017 New York Award Winner

Tue, 27 Jun 2017 10:00:00 EDT

RYE, N.Y., June 27, 2017 /PRNewswire/ -- Curemark announced that CEO Dr. Joan Fallon received the EY Entrepreneur Of The Year 2017 NY Award in the Healthcare category. The award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and...



LifeNome Launches Six New DNA-based Personalized Wellness Apps in Sequencing.com's App Store

Tue, 27 Jun 2017 09:18:00 EDT

(image) NEW YORK, June 27, 2017 /PRNewswire/ -- Sequencing.com, the world's largest marketplace for DNA-powered apps, and LifeNome Inc., a DNA-based wellness AI company, have announced that LifeNome's innovative apps are now available in Sequencing.com's App Store for DNA. The apps include...



Media Files:
https://mma.prnewswire.com/media/410208/Sequencing_Logo.jpg




Survey Shows Intensifying Focus on Cost and Demonstration of Value in Increasingly Competitive Orphan Drug Space

Tue, 27 Jun 2017 09:12:00 EDT

(image) BURLINGTON, Mass., June 27, 2017 /PRNewswire/ -- Decision Resources Group finds that more than 40% of surveyed U.S. physicians perceive an increase over the last three years in the degree of payer challenges they face when prescribing for rare diseases. Separately, the majority of...



Media Files:
https://mma.prnewswire.com/media/75057/decision_resources_group_logo.jpg




Dance Biopharm Appoints Steve Thornton to Board of Directors

Tue, 27 Jun 2017 09:00:00 EDT

(image) SAN FRANCISCO, June 27, 2017 /PRNewswire/ -- Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat diabetes, is pleased to announce the appointment of Steve...



Media Files:
http://dancebiopharm.com




Dragonfly Therapeutics nombra director científico a un líder mundial en inmunoterapias

Tue, 27 Jun 2017 08:51:00 EDT

(image) - Dragonfly Therapeutics nombra director científico al líder mundial en tratamientos basados en linfocitos citolíticos naturales El Dr. Wagtmann, científico de renombre mundial que goza de más de 20 años de experiencia en el sector biotecnológico y farmacéutico, se une al equipo de...



Media Files:
https://mma.prnewswire.com/media/527612/Nicolai_Wagtmann.jpg




Medial EarlySign Partners With Medicover on New EU Pilot Project to Identify Patients at Risk of Harboring Colorectal Cancer

Tue, 27 Jun 2017 08:30:00 EDT

KFAR MALAL, Israel, June 27, 2017 /PRNewswire/ -- Medial EarlySign (earlysign.com), a developer of machine learning tools for data driven medicine, today announced a strategic collaboration with Medicover, a leading international healthcare and diagnostic services provider, to...



Dragonfly Therapeutics nomme le chef de file mondial en thérapie à base de cellules tueuses naturelles (NK) au poste de Conseiller scientifique en chef

Tue, 27 Jun 2017 08:22:00 EDT

(image) Le Dr Wagtmann, médecin de renommée internationale, possédant plus de 20 années d'expérience dans l'industrie biotechnologique et pharmaceutique, a rejoint l'équipe de Dragonfly afin d'accélérer le développement des immunothérapies à base de cellules tueuses naturelles qu'il a récemment mi...



Media Files:
https://mma.prnewswire.com/media/527612/Nicolai_Wagtmann.jpg